JP2006500919A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500919A5
JP2006500919A5 JP2004517500A JP2004517500A JP2006500919A5 JP 2006500919 A5 JP2006500919 A5 JP 2006500919A5 JP 2004517500 A JP2004517500 A JP 2004517500A JP 2004517500 A JP2004517500 A JP 2004517500A JP 2006500919 A5 JP2006500919 A5 JP 2006500919A5
Authority
JP
Japan
Prior art keywords
disease
eczema
crohn
psoriasis
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004517500A
Other languages
English (en)
Japanese (ja)
Other versions
JP4511349B2 (ja
JP2006500919A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/001983 external-priority patent/WO2004003140A2/en
Publication of JP2006500919A publication Critical patent/JP2006500919A/ja
Publication of JP2006500919A5 publication Critical patent/JP2006500919A5/ja
Application granted granted Critical
Publication of JP4511349B2 publication Critical patent/JP4511349B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004517500A 2002-01-18 2003-01-21 サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー Expired - Fee Related JP4511349B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35032502P 2002-01-18 2002-01-18
US38910802P 2002-06-14 2002-06-14
US43536102P 2002-12-19 2002-12-19
PCT/US2003/001983 WO2004003140A2 (en) 2002-01-18 2003-01-21 Cytokine receptor zcytor17 multimers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009246276A Division JP2010043120A (ja) 2002-01-18 2009-10-27 サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー

Publications (3)

Publication Number Publication Date
JP2006500919A JP2006500919A (ja) 2006-01-12
JP2006500919A5 true JP2006500919A5 (enExample) 2009-04-02
JP4511349B2 JP4511349B2 (ja) 2010-07-28

Family

ID=30003762

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004517500A Expired - Fee Related JP4511349B2 (ja) 2002-01-18 2003-01-21 サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー
JP2009246276A Pending JP2010043120A (ja) 2002-01-18 2009-10-27 サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009246276A Pending JP2010043120A (ja) 2002-01-18 2009-10-27 サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー

Country Status (13)

Country Link
US (24) US7494804B2 (enExample)
EP (3) EP2338910B1 (enExample)
JP (2) JP4511349B2 (enExample)
AT (1) ATE547430T1 (enExample)
AU (1) AU2003280410B8 (enExample)
CA (1) CA2473733C (enExample)
CY (1) CY1112787T1 (enExample)
DK (1) DK1576112T3 (enExample)
ES (2) ES2382800T3 (enExample)
IL (3) IL163067A (enExample)
PT (1) PT1576112E (enExample)
SI (1) SI1576112T1 (enExample)
WO (1) WO2004003140A2 (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000075314A1 (en) * 1999-06-02 2000-12-14 Chugai Research Institute For Molecular Medicine, Inc. Novel hemopoietin receptor protein nr10
EP1221482B1 (en) 1999-09-27 2005-12-28 Chugai Seiyaku Kabushiki Kaisha Hemopoietin receptor protein, nr12
US20030096339A1 (en) 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
EP2338910B1 (en) 2002-01-18 2015-07-08 ZymoGenetics, Inc. Cytokine receptor Zcytor17 multimers
US9738700B2 (en) 2002-01-18 2017-08-22 Zymogenetics Inc. ZCYTOR17 heterodimeric cytokine receptor
ATE478944T1 (de) 2002-01-18 2010-09-15 Zymogenetics Inc Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
JP2007068402A (ja) * 2003-12-26 2007-03-22 Bml Inc 免疫応答調節蛋白質
US20060269991A1 (en) * 2004-11-03 2006-11-30 Boehringer Ingelheim Pharmaceuticals, Inc. T cell protein and nucleotides encoding the same
CA2594502A1 (en) * 2005-01-28 2006-08-03 Zymogenetics Inc. Homogeneous preparations of il-31
JP2008530132A (ja) 2005-02-14 2008-08-07 ザイモジェネティクス， インコーポレイテッド Ｉｌ−３１ｒａアンタゴニストを用いて皮膚障害を治療する方法
AU2012202218B2 (en) * 2005-02-14 2014-05-22 National Jewish Medical And Research Center Methods Of Treating Diseases Which Are Mediated By Cutaneous Lymphocyte Antigen Positive Cells
AU2006214325B2 (en) * 2005-02-14 2012-04-05 National Jewish Medical And Research Center Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
CN101198624B (zh) 2005-05-06 2012-10-10 津莫吉尼蒂克斯公司 Il-31单克隆抗体及使用方法
US8101183B2 (en) * 2005-05-06 2012-01-24 Zymogentics, Inc. Variable region sequences of IL-31 monoclonal antibodies
US20130216542A1 (en) 2005-05-06 2013-08-22 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
US7972776B2 (en) 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
EP2749571A3 (en) 2006-01-10 2014-08-13 ZymoGenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using IL-31RA and OSMRb antagonists
IN2014DN10515A (enExample) * 2006-03-31 2015-08-21 Chugai Pharmaceutical Co Ltd
ES2544888T3 (es) 2006-06-08 2015-09-04 Chugai Seiyaku Kabushiki Kaisha Prevención o remedio para enfermedades inflamatorias
US7851144B2 (en) 2006-08-18 2010-12-14 The University Of Washington Compositions and methods for detecting cancer
WO2008025032A1 (en) * 2006-08-25 2008-02-28 Zymogenetics, Inc. Soluble il-27 receptor
ES2548714T3 (es) 2006-09-01 2015-10-20 Zymogenetics, Inc. Anticuerpos monoclonales IL-31 y procedimientos de uso
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100003704A1 (en) 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
CA2672739A1 (en) * 2007-01-10 2008-07-17 Zymogenetics, Inc. Methods of using il-31 to treat airway hyper-responsiveness and asthma
AU2008304778B9 (en) 2007-09-26 2014-05-08 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substitution in CDR
PL3059246T3 (pl) * 2007-09-26 2018-11-30 Chugai Seiyaku Kabushiki Kaisha Zmodyfikowany region stały przeciwciała
BRPI0821145B8 (pt) * 2007-12-05 2021-05-25 Chugai Pharmaceutical Co Ltd uso de um anticorpo anti-nr10 como agente preventivo ou terapêutico para prurido
JP5682995B2 (ja) 2007-12-05 2015-03-11 中外製薬株式会社 抗ｎｒ１０抗体、およびその利用
PT2796466T (pt) 2007-12-07 2018-02-23 Zymogenetics Inc Moléculas de anticorpo humanizado específicas para il-31
HRP20160209T1 (hr) 2008-04-11 2016-03-25 Chugai Pharmaceutical Co Ltd Antigenski vežuća molekula koja se može višekratno vezati na dva ili više antigena
JO3382B1 (ar) * 2008-12-23 2019-03-13 Amgen Inc أجسام مضادة ترتبط مع مستقبل cgrp بشري
JP5717624B2 (ja) 2009-03-19 2015-05-13 中外製薬株式会社 抗体定常領域改変体
EP3674317B1 (en) 2009-03-19 2024-12-11 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant
TWI654203B (zh) 2010-11-30 2019-03-21 中外製藥股份有限公司 具有鈣依存性的抗原結合能力之抗體
EP3636274B1 (en) 2011-01-18 2024-07-17 Bioniz Therapeutics, Inc. Compositions for modulating gamma-c-cytokine activity
WO2014194274A2 (en) 2013-05-30 2014-12-04 Biogen Idec Ma Inc. Oncostatin m receptor antigen binding proteins
US10464982B2 (en) 2014-04-23 2019-11-05 Emory University Compositions of GM-CSF and interleukin fusions for immune modulation and uses related thereto
CN107614016B (zh) 2015-04-14 2022-06-17 中外制药株式会社 包含il-31拮抗剂作为活性成分的用于预防和/或治疗特应性皮炎的药物组合物
EP4650370A2 (en) 2015-04-14 2025-11-19 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
WO2017050878A1 (en) 2015-09-23 2017-03-30 Koninklijke Philips N.V. Modular monitoring device platform with interchangeable modules
WO2018170288A1 (en) 2017-03-15 2018-09-20 Pandion Therapeutics, Inc. Targeted immunotolerance
MX2019013517A (es) 2017-05-24 2020-08-17 Pandion Operations Inc Inmunotolerancia dirigida.
US10322165B2 (en) * 2017-07-26 2019-06-18 Academia Sinica TIFA antagonists and their use for treating diseases
KR102414120B1 (ko) 2017-08-03 2022-06-28 암젠 인크 인터류킨-21 뮤테인 및 치료 방법
US10174091B1 (en) 2017-12-06 2019-01-08 Pandion Therapeutics, Inc. IL-2 muteins
US10946068B2 (en) 2017-12-06 2021-03-16 Pandion Operations, Inc. IL-2 muteins and uses thereof
USRE50550E1 (en) 2017-12-06 2025-08-26 Pandion Operations, Inc. IL-2 muteins and uses thereof
CR20200330A (es) 2018-01-12 2020-12-23 Amgen Inc Anticuerpos anti-pd-1 y métodos de tratamiento
AU2020269255A1 (en) 2019-05-03 2022-01-06 Bioniz Therapeutics, Inc. Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders
CA3141327A1 (en) 2019-05-20 2020-11-26 Pandion Operations, Inc. Madcam targeted immunotolerance
KR20220098046A (ko) 2019-11-20 2022-07-08 추가이 세이야쿠 가부시키가이샤 항체 함유 제제
WO2021168079A1 (en) 2020-02-21 2021-08-26 Pandion Operations, Inc. Tissue targeted immunotolerance with a cd39 effector
JP2023532272A (ja) * 2020-06-24 2023-07-27 バイオニズ リミテッド ライアビリティー カンパニー サイトカイン放出症候群およびサイトカインストーム関連障害の治療用の、ｉｌ－２、ｉｌ－９およびｉｌ－１５のシグナル伝達を標的とするアンタゴニストペプチド
MX2023002482A (es) 2020-09-01 2023-03-08 Chugai Pharmaceutical Co Ltd Composicion farmaceutica para prevencion y/o tratamiento de prurito por dialisis que comprende antagonista de interleucina 31 (il-31) como ingrediente activo.
WO2025226834A1 (en) 2024-04-23 2025-10-30 Attovia Therapeutics, Inc. Il31-binding polypeptides and uses thereof

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54046B1 (en) 1981-08-25 1989-05-24 Celltech Ltd Expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4603044A (en) 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0184576B1 (en) 1984-12-06 1990-06-27 Fina Research S.A. Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
EP0721983A1 (en) 1988-01-22 1996-07-17 ZymoGenetics, Inc. Methods of producing biologically active peptide dimers
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
EP0561960A1 (en) 1990-12-13 1993-09-29 Immunex Corporation Leukemia inhibitory factor receptors
JP3202999B2 (ja) 1991-01-31 2001-08-27 協和醗酵工業株式会社 肝移行性リポソーム製剤
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
JPH08502646A (ja) 1992-09-14 1996-03-26 ファイザー・インコーポレイテッド 不死化細胞およびその使用
CA2168202A1 (en) 1993-07-30 1995-03-16 Joseph Dougherty Efficient gene transfer into primary lymphocytes
EP0745132A1 (en) 1994-02-14 1996-12-04 ZymoGenetics, Inc. Method for preparing orphan receptor ligands
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
AU704723B2 (en) * 1994-12-29 1999-04-29 Chugai Seiyaku Kabushiki Kaisha Antitumor agent effect enhancer containing IL-6 antagonist
US6074849A (en) * 1995-07-19 2000-06-13 Genetics Institute, Inc. Polynucleotides encoding human CTLA-8 related proteins
JP2000500014A (ja) 1995-11-09 2000-01-11 ザイモジェネティクス，インコーポレイティド ピヒア・メタノリカ中で異種ポリペプチドを生産するための組成物と方法
US5792850A (en) * 1996-05-23 1998-08-11 Zymogenetics, Inc. Hematopoietic cytokine receptor
AU708572B2 (en) 1996-07-17 1999-08-05 Zymogenetics Inc. Preparation of (pichia methanolica) auxotrophic mutants
AU718510B2 (en) 1996-07-17 2000-04-13 Zymogenetics Inc. Transformation of pichia methanolica
JP4215172B2 (ja) 1996-12-03 2009-01-28 アムジェン フレモント インク． 複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
GB9819420D0 (en) 1998-09-07 1998-10-28 Glaxo Group Ltd Novel receptor
EP1950299A1 (en) 1999-06-01 2008-07-30 Schering Corporation Mammalian receptor proteins; related reagents and methods
WO2000075314A1 (en) 1999-06-02 2000-12-14 Chugai Research Institute For Molecular Medicine, Inc. Novel hemopoietin receptor protein nr10
MXPA02003897A (es) * 1999-10-20 2002-12-13 Genentech Inc Modulacion de la diferenciacion de celulas t para el tratamiento de enfermedades mediadas por las celulas t auxiliares.
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2412211A1 (en) 2000-06-23 2002-01-03 Genetech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
EP2258725A3 (en) * 2000-06-26 2014-09-17 ZymoGenetics, L.L.C. Cytokine receptor zcytor17
US20030096339A1 (en) * 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
MXPA03002971A (es) * 2000-10-06 2004-05-05 Immunex Corp Receptores de hematopoyetina hpr1 y hpr2.
WO2002077230A1 (fr) 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Variants d'epissage nr10
ATE478944T1 (de) 2002-01-18 2010-09-15 Zymogenetics Inc Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
EP2338910B1 (en) * 2002-01-18 2015-07-08 ZymoGenetics, Inc. Cytokine receptor Zcytor17 multimers
US7303896B2 (en) * 2002-02-25 2007-12-04 Genentech, Inc. Nucleic acid encoding novel type-1 cytokine receptor GLM-R
US7552497B2 (en) * 2002-03-26 2009-06-30 Colgate-Palmolive Company Powered toothbrush with rotating sections
JP2008530132A (ja) 2005-02-14 2008-08-07 ザイモジェネティクス， インコーポレイテッド Ｉｌ−３１ｒａアンタゴニストを用いて皮膚障害を治療する方法

Similar Documents

Publication Publication Date Title
JP2006500919A5 (enExample)
JP2008540738A5 (enExample)
JP2004538039A5 (enExample)
JP2006503588A5 (enExample)
JP2005510235A5 (enExample)
JP2007518723A5 (enExample)
JP2006523595A5 (enExample)
JP2004535435A5 (enExample)
JP2009537315A5 (enExample)
JP2004535456A5 (enExample)
NO20053860D0 (no) COP 1 for behandling av inflammatorisk tarmsykdom.
JP2011035619A5 (enExample)
JP2009144156A5 (enExample)
EG25196A (en) Process for the manufacture of 1,2-Dichloroethane
JP2007500346A5 (enExample)
JP2005515404A5 (enExample)
JP2005525451A5 (enExample)
JP2006507484A5 (enExample)
JP2009533644A5 (enExample)
JP2006512466A5 (enExample)
JP2006505391A5 (enExample)
JP2008534513A5 (enExample)
JP2005527457A5 (enExample)
JP2007520063A5 (enExample)
JP2011502199A5 (enExample)